Virus Filtration Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Virus Filtration Market is segmented by Products (Filtration Systems, Kits, Reagents, and Consumables, and Services), Application, End User, and Geography.

Market Snapshot

Virus Filtration Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 11.2 %
Virus Filtration Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Virus Filtration Market Overview

The virus filtration market is expected to observe good growth over the forecast period. The major factors attributing to the growth of the virus filtration market are increasing R&D spending, growth in the biopharmaceutical industry, and the adoption of single-use technologies. Also, factors such as the increasing prevalence of chronic diseases are contributing to the growth of the market. The increasing prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders, are anticipated to propel the demand for biologics. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. This raises the research and development expenditures by biopharmaceutical companies to bring more innovation where virus filtration techniques are highly useful. These factors promote the growth of the virus filtration market.

Scope of the Report

Virus filtration is an important step in the biopharmaceutical industry, as it ensures that the products are adequately purified to be fit for consumption. Virus filtration also helps to optimize process economics and prevents the loss of valuable products.

By Product
Filtration Systems
Kits, Reagents, and Consumables
By Application
Vaccines and Therapeutics
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Other Products
Medical Devices
Water Purification
Air Purification
By End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East & Africa
South Africa
Rest of Middle-East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Kits, Reagents, and Consumables Segment is Expected to Hold the Majority Share of the Market

The kits, reagents, and consumables segment serves as an important category in the virus filtration market. The reagents help to reduce the potential of iatrogenic transmission of pathogenic viruses. In the process evaluation, the reagents help to identify the virus that is likely to contaminate the cell-substrate or any other reagents or materials used in the process.

Qiagen and Merck Millipore are two of the widely known companies for reagents and kits for virus filtration. The samples used in the biopharmaceuticals production may include blood, plasma, serum, or bodily fluids, or any monoclonal antibody and recombinant proteins. Even several biologic and pharmaceutical-based companies are opting to invest more in R&D of vaccines, protein therapeutics, blood products, cellular therapy products, gene therapy products, tissue products, and stem cell products. The demand for these kits and reagents is driving the market studied.

Virus Filtration Market Share

North America Dominates the Market and Expected to do Similar Over the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing incidence of diseases and the presence of more number of pharmaceutical companies in the region. In the North American region, the United States holds the largest market share. Additionally, in recent years, there has been increased regulatory scrutiny of incidents related to adventitious viruses in manufacturing processes. Owing to the increased R&D of biopharmaceutical companies, the demand for biologics is expected to drive the viral filtration market, during the forecast period.

Virus Filtration Market Forecast

Competitive Landscape

The virus filtration market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market studied. With the rising R&D of biopharmaceutical companies and the high prevalence of diseases, few other smaller players are expected to enter into the market studied in the coming years. Some of the major players of the market studied are Asahi Kasei Medical Co. Ltd, Charles River Laboratories International Inc., General Electric Company, Pall Corporation, and Merck KgaA, among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing R&D Spending

      2. 4.2.2 Growth in the Biopharmaceutical Industry

      3. 4.2.3 Adoption of Single-use Technologies

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations for Validation of Filtration Products

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Filtration Systems

      2. 5.1.2 Kits, Reagents, and Consumables

      3. 5.1.3 Services

    2. 5.2 By Application

      1. 5.2.1 Biological

        1. Vaccines and Therapeutics

        2. Blood and Blood Products

        3. Cellular and Gene Therapy Products

        4. Tissue and Tissue Products

        5. Other Products

      2. 5.2.2 Medical Devices

      3. 5.2.3 Water Purification

      4. 5.2.4 Air Purification

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Contract Research Organizations (CROs)

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East & Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Asahi Kasei Medical Co. Ltd

      2. 6.1.2 Charles River Laboratories International Inc.

      3. 6.1.3 General Electric Company

      4. 6.1.4 Lonza Group Ltd

      5. 6.1.5 Merck KgaA

      6. 6.1.6 Danaher Corporation (Pall Corporation)

      7. 6.1.7 Sartorius AG

      8. 6.1.8 Clean Cell Inc.

      9. 6.1.9 Thermo Fischer Scientific Inc.

      10. 6.1.10 Wuxi Biologics

    2. *List Not Exhaustive

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Virus Filtration Market market is studied from 2018 - 2026.

The Virus Filtration Market is growing at a CAGR of 11.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Asahi Kasei Medical Co. Ltd, Charles River Laboratories International Inc., Merck KgaA, Danaher Corporation, GE Healthcare are the major companies operating in Virus Filtration Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!